Cytori Therapeutics reported $-3926000 in EBIT for its first fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Ebit Change
Baxter International BAX:US $ 531M 108M
Cerus CERS:US $ -9848000 2.89M
Cytori Therapeutics CYTX:US $ -3926000 285K
Dr.Reddys Laboratories DRRD:IN 9B 263M
Genocea Biosciences GNCA:US $ -15773000 2.36M
Haemonetics HAE:US $ 87.48M 45.7M
Infinity Pharmaceuticals INFI:US -12407000 907K
Merrimack Pharmaceuticals MACK:US $ -577000 104K
Mirati Therapeutics MRTX:US $ -184218000 12.86M
Northwest Biotherapeutics NWBO:US -12286000 1.61M
Starpharma Holdings Ltd SPL:AU -8449000 853K
Sun Pharmaceuticals SUNP:IN 16.23B 4.4B
Teva Pharmaceutical TEVA:IT 789M 182M